VELA Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,818
| Closed | -$348K | – | 144 |
|
|
2023
Q4 | $348K | Sell |
1,818
-1,599
| -47% | -$306K | 0.13% | 127 |
|
|
2023
Q3 | $605K | Hold |
3,417
| – | – | 0.27% | 100 |
|
|
2023
Q2 | $649K | Hold |
3,417
| – | – | 0.3% | 96 |
|
|
2023
Q1 | $684K | Buy |
3,417
+92
| +3% | +$18.4K | 0.31% | 94 |
|
|
2022
Q4 | $790K | Hold |
3,325
| – | – | 0.39% | 81 |
|
|
2022
Q3 | $666K | Buy |
3,325
+350
| +12% | +$70.1K | 0.38% | 79 |
|
|
2022
Q2 | $434K | Hold |
2,975
| – | – | 0.25% | 104 |
|
|
2022
Q1 | $486K | Buy |
2,975
+544
| +22% | +$88.9K | 0.31% | 93 |
|
|
2021
Q4 | $412K | Buy |
+2,431
| New | +$412K | 0.28% | 103 |
|